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Respiratory infections have been implicated in sudden infant death syndrome (SIDS). As
interferon-γ (IFN-γ) is a major response to virus infection, we examined (1) the frequency
of single nucleotide polymorphism (SNP), IFNG T+874A, in SIDS infants, their parents,
and ethnic groups with different incidences of SIDS; (2) model systems with a monocytic
cell line (THP-1) and human peripheral blood monocytes (PBMC) for effects of levels of
IFN-γ on inflammatory responses to bacterial antigens identified in SIDS; (3) interactions
between genetic and environmental factors on IFN-γ responses. IFNGT+874A genotypes
were determined for SIDS infants from three countries; families who had a SIDS death;
populations with high (Indigenous Australian), medium (Caucasian), and low (Bangladeshi)
SIDS incidences.The effect of IFN-γ on cytokine responses to endotoxin was examined in
model systems withTHP-1 cells and human PBMC.The IFN-γ responses to endotoxin and
toxic shock syndrome toxin (TSST-1) were assessed in relation to genotype, gender, and
reported smoking.There was a marginal association with IFNGT+874A genotype and SIDS
(p=0.06). Indigenous Australians had significantly higher proportions of the IFNGT+874A
SNP (TT) associated with high responses of IFN-γ. THP-1 cells showed a dose dependent
effect of IFN-γ on cytokine responses to endotoxin. For PBMC, IFN-γ enhanced interleukin
(IL)-1β, IL-6, and tumor necrosis factor-α responses but reduced IL-8 and IL-10 responses.
Active smoking had a suppressive effect on baseline levels of IFN-γ.There was no effect of
gender or genotype on IFN-γ responses to bacterial antigens tested; however, significant
differences were observed between genotypes in relation to smoking.The results indicate
virus infections contribute to dysregulation of cytokine responses to bacterial antigens
and studies on physiological effects of genetic factors must include controls for recent or
concurrent infection and exposure to cigarette smoke.
Keywords: sudden infant death syndrome, IFN-γ, ethnicity, cigarette smoke, cytokines
INTRODUCTION
The peak in sudden infant death syndrome (SIDS) occurs dur-
ing the developmental period in which infants have low levels of
specific antibody protection, either maternal or actively acquired
immunity. They are dependent on their innate responses to deal
with new infectious agents they encounter in their environment.
Infection and inflammatory responses have been implicated in
many of these deaths and we have examined the hypothesis that
some SIDS deaths occur as a result of dysregulation of inflamma-
tory responses which can affect physiological systems suggested to
be involved in triggering these deaths (1).
There is a growing body of evidence that infection (1–3) and
the inflammatory response to these infections (1, 4, 5) play a role
in both SIDS and sudden unexpected death in infancy (SUDI).
Inflammatory changes, particularly in the respiratory tract, are
common findings in SIDS. It has been suggested that these findings
reflect recent infections, symptoms of which have been noted in
the 2 weeks prior to death for over 40% of SIDS infants (6, 7). Mild
respiratory infections have been noted prior to death, but no sin-
gle virus has been implicated (8). In infants, virus infections have
been demonstrated to enhance the number and variety of bacterial
species in the nasopharynx (9), particularly among infants sleep-
ing in the prone position. While specific virus infections were not
identified among SIDS infants, it was noted that there was a signifi-
cantly higher proportion of coliform organisms in the respiratory
tract of many (10). Both Staphylococcus aureus and Escherichia
coli were identified in a significantly higher proportion of SUDI
infants than infants who died of known causes (2, 3).
In animal models, induction of pro-inflammatory cytokines
such as interferon-γ (IFN-γ) contribute to the severity of a host’s
responses to either infectious agents or their products, and this
can be greatly enhanced by a co-existing virus infection (11–14).
Toxigenic bacteria or their toxins have been implicated in the
etiology of SIDS (15–20). Priming with an asymptomatic virus
www.frontiersin.org March 2015 | Volume 6 | Article 107 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Moscovis et al. IFN-γ and SIDS
infection can significantly reduce the concentration of bacterial
toxins needed to induce death.
There have been reports that levels of IFN-γ responses differ
between the single nucleotide polymorphisms (SNPs) genotypes
(21, 22). We have demonstrated in previous studies that these can
vary among different ethnic groups (23) and that there are inter-
actions between genotypes and exposure to environmental agents
such as cigarette smoke (24). As virus infections and exposure
to cigarette smoke are both significant risk factors for SIDS, our
study tested the following hypotheses: (1) the single nucleotide
polymorphism IFNG T+ 874A genotype associated with higher
IFN-γ responses might be over-represented among SIDS infants
or ethnic groups in which there is a higher incidence of SIDS;
(2) as a surrogate for virus infection, exposure to IFN-γ would
significantly alter cytokine responses from human leukocytes to
bacterial antigens identified in SIDS infants; (3) cigarette smoking
might affect IFN-γ responses to bacterial toxins in vitro, as noted
previously for other cytokines (24, 25).
SUBJECTS AND METHODS
Approval for the study was obtained from the Lothian Health
Ethics Committee (UK), Hunter Area Research Ethics Commit-
tee (Australia), and the University of Newcastle Human Research
Ethics Committee (Australia).
ASSESSMENT OF IFNG T+ 874A SNP
Buccal epithelial cells were collected from Caucasian parents of
SIDS infants from Britain (n= 34) and Australia (n= 60), and
their matched controls with no family history of SIDS (Britain
n= 59, Australia n= 55).
Paraffin-fixed samples of tissue from SIDS infants were
obtained from Australia (n= 17), Hungary (n= 21), and Germany
(n= 47). Stored frozen whole blood samples from Indigenous
Australians (n= 123) and buccal epithelial cells from Bangladeshis
(n= 32) were used as DNA sources for comparisons between eth-
nic groups. The methods for extraction of DNA from the samples
have been described previously (24–26).
To genotype IFNG T+ 874A (rs2430561) a custom made allelic
discrimination polymerase chain reaction (PCR) assay was manu-
factured (PE Applied Biosystems). Primers: 5′ GCT GTC ATA ATA
ATA TTC AGA CAT TCA CAA TTG AT 3′; 5′ TGC GAG TGT GTG
TGT GTG T 3′ and probes: 5′ CAC AAA ATC AAA TCT CAC ACA
C 3′; 5′ ACA AAA TCA AAT CAC ACA CAC 3′ were provided in a
40× assay mix.
Each PCR reaction contained 10 ng of sample DNA, 1× Assay
mix, and 1× TaqMan Universal PCR Master Mix (PE Applied
Biosystems) made up to a final volume of 5µl with sterilized
MilliQ water. PCR was performed using the ABI PRISM 7900HT
sequence detection system (PE Applied Biosystems) at the follow-
ing thermal cycling conditions: 50°C for 2 min; 95°C for 10 min;
92°C for 15 s; and 60°C for 1 min, for 40 cycles.
Data were analyzed using the statistical software package Statis-
tics/Data Analysis™(STATA) Version 8.0 (Stata Corporation, Col-
lege Station, TX, USA). The Chi-square (χ2) test or Fisher’s exact
test, if appropriate, was used to assess the distribution of IFNG
T+ 874A in SIDS infants, parents of SIDS infants, and between
ethnic groups. Deviation of IFNG T+ 874A genotype distribution
from Hardy–Weinberg equilibrium (HWE) was assessed using
the χ2 test.
ASSESSMENT OF THE EFFECTS OF IFN-γ ON RESPONSES TO
BACTERIAL ANTIGENS
The THP-1 human monocytic cell line used in previous studies of
inflammatory responses to bacterial endotoxin (27) was used in
preliminary studies to determine concentrations of components
to be used in the model system (28).
Collection, isolation, and storage of human peripheral blood
monocytic cells (PBMC) have been described previously (29).
Buffy coats from 14 male (n= 14) and 14 female (n= 14) donors,
aged 20–55 years, were purchased from the Australian Red Cross
Blood Service (ARCBS) (Sydney, NSW, Australia). Ethical permis-
sion was obtained from University of Newcastle Human Research
Ethics Committee (H-229-0606) and ARCBS Ethics Committee
(07-11NSW-07) for the purchase and use of human buffy coats for
the purposes of the study. PBMC were collected from each donor
for in vitro cytokine stimulation assays and plasma was collected
for the assessment of cotinine for evidence of exposure to ciga-
rette smoke, a confounding variable for altered cytokine responses.
Donors with detectable levels of cotinine were excluded from the
analysis. Only ARCBS donor samples that were cleared for infec-
tious agents were received. Buffy coats were processed within 24 h
of collection.
Blood samples (10–20 ml) were collected from British parents
of SIDS infants (n= 34) and control individuals (n= 59) who had
no family history of SIDS. Leukocytes were isolated and stored as
described previously (24–26).
ANALYSIS OF EXPOSURE TO CIGARETTE SMOKE
As described previously (29), plasma from the samples from
ARCBS donors were assessed for exposure to cigarette smoke by
a semi-quantitative commercial competitive enzyme immunoas-
say (EIA) kit according to manufacturer’s instructions (OraSure
Technologies Inc., Bethlehem, PA, USA). To prevent false negative
classification of exposure to cigarette smoke, the qualitative cut-off
of the assay was lowered from the recommended 25 to 10 ng ml−1.
Donors with detectable levels of cotinine were excluded from
stimulation assays.
STIMULATION ASSAYS
Conditions for experiments with the THP-1 cells have been
described previously (28).
Peripheral blood monocytic cells from the ARCBS donors
(n= 28) were assessed for in vitro cytokine responses to a common
bacterial antigen, E. coli lipopolysaccharide (LPS) (50 ng ml−1).
IFN-γ (10 ng ml−1) was used as a surrogate for virus infection. A
water-soluble cigarette smoke extract (CSE) was used as a sur-
rogate for exposure to cigarette smoke. The method has been
described previously (29).
The leukocytes from British parents of SIDS infants were
assessed for inflammatory responses to TSST-1 and LPS as
described previously (24–26). All samples were coded and tested
without knowing the smoking status of the donors. Leuko-
cytes (1× 106 cells ml−1) were stimulated in vitro with 0.01,
1µg ml−1 E. coli endotoxin or 0.5µg ml−1 toxic shock syndrome
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toxin (TSST-1) (Sigma, Poole, Dorset, UK) for 24 h. Cell culture
conditions have been described previously (24–26).
ANALYSIS OF CYTOKINE RESPONSES
Supernatants from the THP-1 and PBMC assays were measured
for IL-1β, IL-6, tumor necrosis factor-α (TNF-α), IFN-γ, IL-8,
and IL-10 using Bio-Rad 6-plex assays and the Luminex 200 ana-
lyzer. Cytokine concentrations (pg ml−1) were calculated from the
standard curve using the Luminex 2.3 Software. Data were ana-
lyzed using STATA™ Version 10.0. Mean donor cytokine measure-
ments were used for statistical analysis. The Wilcoxon matched-
pairs signed ranks test was used to assess differences in cytokine
responses between treatment groups. The significance level was set
at p< 0.05.
Supernatants from assays with leukocytes from the British SIDS
and control families were measured for IFN-γ levels using enzyme-
linked immunosorbent assays (ELISA) kits (R&D Systems, Min-
neapolis, MN, USA) according to manufacturer’s instructions.
Results were expressed as ng ml−1 derived from the standard
curves obtained using a recombinant human IFN-γ standard
(R&D Systems). The result for each group assessed was reported
as the median value. Student’s t -test was used on log-transformed
data to assess differences in IFN-γ responses of smokers and non-
smokers and of males and females in relation to genotype. The
significance level for all tests was set at p< 0.05.
RESULTS
ANALYSIS OF GENOTYPES OF IFNG T+ 874A
The distributions of IFNG T+ 874A genotypes among the differ-
ent groups assessed are summarized in Table 1. Distributions were
in HWE for each of the groups assessed, except for the Australian
SIDS infants.
DISTRIBUTION OF IFNG T+ 874A AMONG SIDS INFANTS
There were no significant differences in the IFNG T+ 874A dis-
tribution in SIDS infants from different countries (Table 1). The
predominant genotype among Australian SIDS infants was AA
(9/16, 56%); approximately half of Hungarian (4/8, 50%) and
German (21/45, 47%) infants possessed the TA genotype.
The distribution of IFNG T+ 874A in the Australian control
population approached a significant difference from that observed
for Australian SIDS infants (p= 0.06). The genotype distribution
of the Australian SIDS infant group was inversely proportional to
the distribution of the control population. There was a predom-
inance of the TT (25%) and AA (56%) genotypes, and an under
representation of the TA (19%) genotype. The Australian control
population was similar to all other populations, with approxi-
mately half the population (51%) with the TA genotype. The under
representation of the TA genotype in the Australian SIDS infant
group caused the genotype distribution to be significantly different
from that of the HWE (p= 0.02). No significant differences were
detected between the distributions of IFNG T+ 874A genotype
for the combined SIDS infant group compared to the Caucasian
controls (p= 0.52).
ASSESSMENT OF IFNG T+ 874A AMONG PARENTS OF SIDS INFANTS
Differences in the distribution of IFNG T+ 874A genotype among
parents of SIDS infants were not statistically significant compared
Table 1 | IFNG T+874A allele frequency distributions across
populations.
Ethnicity Group Allele fre-
quency (%)
Sample
size (n)
pValue (p)
TT TA AA
British SIDS Parents 12 56 32 34 0.53
British Control Parents 14 44 42 59
Australian SIDS Parents 13 55 32 60 0.77
Australian Control Parents 18 51 31 55
Australian SIDS Infants 25 19 56 16 0.06a
Hungarian SIDS Infants 13 50 38 8 0.89b 0.39c
German SIDS Infants 22 47 31 45 0.12d
Combined SIDS Infants 22 41 38 69 0.52e
Bangladeshi Control 13 50 38 32 0.93f
Indigenous
Australian
Control 39 49 12 75 <0.01g
<0.01h
Caucasian Control 16 47 37 114
aAustralian SIDS infants vs. Australian control parents.
bHungarian SIDS infants vs. German SIDS infants.
cHungarian SIDS infants vs. Australian SIDS infants.
dGerman SIDS infants vs. Australian SIDS infants.
eCombined SIDS infants vs. Caucasian control.
fBangladeshi control vs. Caucasian control.
gIndigenous Australian vs. Caucasian control.
hIndigenous Australian vs. Bangladeshi control.
to their respective control populations (Table 1). Parents of SIDS
infants recruited from Britain showed an increased proportion of
individuals with the TA genotype compared to the matched British
controls but this was not significant (p= 0.53). Parents of SIDS
infants recruited from Australia had a similar distribution to their
control population, with the majority of individuals possessing
the TA genotype (p= 0.77).
DISTRIBUTION OF IFNG T+ 874A IN DIFFERENT ETHNIC GROUPS
As there were no differences between the distribution of IFNG
T+ 874A genotype for British and Australian control populations,
these data were combined for further comparison with samples
from ethnic groups with low incidences of SIDS (Bangladeshi) or
high incidences (Indigenous Australian) compared with Caucasian
populations. The majority of each population possessed the TA
genotype. The distribution of IFNG T+ 874A genotype was simi-
lar for the Caucasian and Bangladeshi populations; however, both
were significantly different from the Indigenous Australian popu-
lation (p< 0.01) (Table 1). The Aboriginal Australian population
had a significant increase in the proportion of the individuals
with the TT genotype compared to the Caucasian and Bangladeshi
populations.
EFFECTS OF IFN-γ AND CSE ON CYTOKINE RESPONSES ELICITED BY
LPS FROM THP-1 CELLS
In the preliminary experiments with THP-1 cells, two concentra-
tions of IFN-γ were tested (1 and 10 ng ml−1) to assess the effect
of dose on pro-inflammatory responses to LPS. TSST was not
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FIGURE 1 | Effects of IFN-γ, 1 ngml−1 (IFN 1) or 10ngml−1 (IFN 10) on cytokine responses ofTHP-1 cells to LPS (50ngml−1).
assessed in these preliminary studies as previous work indicated
that THP-1 cells did not respond to the toxin. IL-6 was not elicited
from THP-1 cells in the absence of IFN-γ. The higher concentra-
tion of IFN-γ induced significantly higher levels of IL-1β, IL-6, and
TNF-α (Figure 1). The anti-inflammatory IL-10 was not detected
under any of the conditions tested.
Because our previous studies indicated cigarette smoke expo-
sure could significantly affect cytokine responses in the model
systems tested (24), we assessed the effects of CSE alone or CSE and
IFN-γ on responses to LPS. Pre-treatment of THP-1 cells with CSE
resulted in decreased responses to LPS. Although the higher dose
of CSE (0.001 cigarette ml−1) appeared to reduce IL-1β, TNF-α,
and IFN-γ responses, the effect was not significant. Both low and
high concentrations of CSE-enhanced IL-8 responses, but these
were not significant. CSE exposure did not have a significant effect
on responses induced with LPS from IFN-γ primed THP-1 cells.
EFFECTS OF IFN-γ AND CSE ON CYTOKINE RESPONSES FROM PBMC
The PBMC from 28 donors were used to assess the effect of prim-
ing with 10 ng ml−1 IFN-γ on cytokine responses to LPS. A similar
pattern of enhancement of pro-inflammatory responses elicited
by the IFN-γ-primed cells was observed with PBMC from blood
donors. CSE exposure reduced the effects of IFN-γ priming on
LPS stimulation of pro-inflammatory cytokines IL-1β, IL-6, and
TNF-α. In contrast to results with THP-1 cells, IFN-γ priming
significantly reduced IL-8 responses and the anti-inflammatory
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FIGURE 2 |The effect of IFN-γ (10 ngml−1) pre-treatment on LPS (50ngml−1) stimulation of IL-1β, IL-6,TNF-α, IL-8 and IL-10 from PBMC (n=28)
***p<0.0001.
IL-10 responses of PBMC to LPS (Figure 2). LPS stimulated cells
pre-treated with both IFN-γ and CSE had the lowest responses for
both IL-8 and IL-10 (Figure 3).
EFFECT OF SMOKING, GENOTYPE, AND GENDER ON IFN-γ RESPONSES
TO LPS OR TSST-1
The assays with PBMC from SIDS parents and unrelated individ-
uals were used to assess the effects of smoking and genotype on
IFN-γ responses to LPS or TSST-1. The results are summarized in
Table 2 and described below.
Smoking
Smoking had a small but significant suppressive effect on
baseline IFN-γ levels (1 ng ml−1) compared to non-smokers
(4.15 ng ml−1) (p< 0.01). This effect disappeared when cells were
stimulated with 0.01 or 1µg ml−1 LPS or 1µg ml−1 TSST.
Genotype
When analyzed irrespective of smoking status, there were no signif-
icant differences between IFN-γ responses among IFNG T+ 874A
genotypes for either of the stimulants.
Gender
Overall, there were no differences in IFN-γ responses of cells from
males compared with those from females. When smoking status
was assessed in relation to gender, there was a significant differ-
ence in the IFN-γ response to 1µg ml−1 TSST-1 for non-smokers:
males (567 ng ml−1); females (1,167 ng ml−1) (p= 0.01). This
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trend was also observed for 1µg ml−1 LPS; however, differences
were not significant (p> 0.05).
INTERACTIONS BETWEEN GENOTYPE AND SMOKING IN RELATION TO
IFN-γ RESPONSES TO LPS
The IFN-γ responses of cells from donors with the TT geno-
type to 0.01µg ml−1 LPS was significantly decreased in smok-
ers (1.85 ng ml−1) compared to non-smokers (145.8 ng ml−1)
(p= 0.02). For non-smokers, the reverse pattern was observed;
IFN-γ responses of TT donors were higher than those of the
other genotypes but the differences were not significant. The IFN-
γ responses to 0.01µg ml−1 LPS from cells of smokers with the
TT genotype (1.85 ng ml−1) was significantly lower compared to
those from cells of smokers with the TA (69.9 ng ml−1) (p< 0.01)
or AA genotypes (75.1 ng ml−1) (p= 0.01).
INTERACTIONS BETWEEN GENOTYPE AND SMOKING IN RELATION TO
IFN-γ RESPONSES TO TSST
Smokers had lower baseline IFN-γ levels than non-smokers.
For individuals with the AA genotype, smokers had significantly
lower IFN-γ responses (1.85 ng ml−1) compared to non-smokers
(6.6 ng ml−1) (p= 0.03).
Differences between genotypes were observed for smokers
when cells were stimulated with 1µg ml−1 TSST. Cells from
smokers with the TA genotype (2,039 ng ml−1) had significantly
higher IFN-γ responses than those with the TT (1,039 ng ml−1)
(p= 0.03) or AA genotypes (1,292 ng ml−1) (p= 0.05) (Table 2).
When genotypes were assessed in relation to smoking sta-
tus, there was a significant difference for the TA genotype. Cells
from smokers had higher IFN-γ responses to 1µg ml−1 TSST
(2,039.7 ng ml−1) compared to non-smokers (1,136.1 ng ml−1)
(p= 0.01).
DISCUSSION
We found no significant associations with the IFNG T+ 874A
SNP genotypes and SIDS. As found for the previous report on a
British population (30), there was a marginal difference between
the SIDS and local control groups (p= 0.06) in the distribution of
the IFNG T+ 874A genotype; however, the distribution of the
genotypes between European and Australian SIDS infants was
different. Among the European infants, the TA genotype was pre-
dominant; but among the Australian infants the AA genotype was
predominant (56%).
It is not unusual for cytokine gene polymorphisms to differ
between countries, particularly among disease cohorts. Differ-
ences between countries reinforce the need for local controls and
caution exercised for interpretation of differences between dis-
ease and control groups from different ethnic backgrounds and
countries.
Due to the under representation of the TA genotype, the geno-
type distribution of the Australian SIDS infant group was out of
HWE. This was observed for two other SNPs previously assessed
in this population; IL1RN T+ 2018C and IL10 G-1082A (24, 26).
The decrease in the heterozygous genotype of IFNG T+ 874A,
IL1RN T+ 2018C, and IL10 G-1082A in the Australian SIDS
infant population indicates that there is bias in the selection of the
population. This might highlight the importance of these SNPs in
the etiology of SIDS in Australia.
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FIGURE 3 | Combined effects of IFN-γ and CSE on IL-8 and IL-10
responses of PBMC to LPS (n=28) ***p<0.0001.
This study has again demonstrated the differences in distri-
butions of cytokine gene polymorphisms among ethnic groups.
There is an increased proportion of individuals with IFNG
T+ 874A TT genotype in the Indigenous Australian popula-
tion compared to Caucasian and Bangladeshi populations. No
Indigenous Australian SIDS infants were examined in the study.
In general, the effect of IFN-γ was similar for both THP-1
and PBMC models, enhancing pro-inflammatory responses IL-
1β, IL-6, and TNF-α to stimulation with LPS. In contrast to
results obtained with THP-1 cells, IFN-γ significantly reduced IL-
8 responses of PBMC to LPS. Addition of CSE to the THP-1 cells
primed with IFN-γ did not significantly alter the responses com-
pared with priming cells with IFN-γ only. Addition of CSE to
the PBMC primed with IFN-γ reduced the enhanced IL-1β, IL-
6, and TNF-α responses to LPS. IFN-γ significantly reduced the
CSE-enhanced IL-8 responses to LPS. Potentially, the most sig-
nificant physiological effect was the reduction in IL-10 responses
in the presence of both IFN-γ and CSE (Figure 3). If the effects
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Table 2 | Median IFN-γ levels of 1×106 cells/ml leukocytes stimulated in vitro withTSST and endotoxins (LPS), assessed by IFNG T+874A
genotype and smoking status.
Smoking status IFNG +874A Gender Median IFN-γ response (ng/ml)
to toxin (µg/ml)
Sample
size (n)
Baseline TSST-1 1 LPS 1 LPS 0.01
Smoker All All 1 1,542 467 55 45
Non-smoker 4 1,074 559 88 74
All TT All 1 895 821 51 15
TA 1 1,357 613 83 48
AA 5 1,452 477 90 41
All All Male 1 893 874 88 26
Female 1 1,135 620 57 52
Smoker TT All 1 1,039 440 2 4
TA 1 2,040 550 70 11
AA 2 1,293 468 75 17
Non-smoker TT 3 895 928 146 31
TA 3 1,136 623 86 18
AA 7 1,477 525 104 23
Smoker All Male 1 1,950 1,120 94 10
Non-smoker 3 567 490 88 16
Smoker Female 1 927 490 48 19
Non-smoker 5 1,167 638 69 33
Smoker TT Male 1 2,857 821 3 1
TA 1 2,121 2,260 432 4
AA 1 1,822 359 16 3
Non-smoker TT 1 215 812 158 2
TA 1 647 406 83 9
AA 386 550 570 421 2
Smoker TT Female 1 1,039 607 12 2
TA 2 808 340 51 6
AA 5 1,293 664 75 10
Non-smoker TT 6 1,818 1,411 214 6
TA 1 1,151 1,243 51 10
AA 7 831 477 69 15
of these two risk factors for SIDS demonstrated in vitro reflect
the responses to infection in vivo, the combined effects of ciga-
rette smoke and virus infection on reduction of IL-10 could result
in significant dysregulation of pro-inflammatory responses. We
have previously demonstrated a dose-dependent reduction in pro-
inflammatory responses in our model system with increasing levels
of IL-10 (24).
Genotype alone was not responsible for differences in IFN-γ
responses. When variables were assessed independently, few differ-
ences were observed. Smoking had a small, but suppressive effect
on baseline IFN-γ levels. There was no effect of gender or IFNG
T+ 874A genotype on IFN-γ responses.
When the effects of smoking status and gender on IFN-γ
responses were assessed, the only difference between genders was
among non-smokers; males had reduced IFN-γ response to TSST-
1. Gender differences in cytokine responses have been previously
described (29, 31, 32) and are thought to be associated with the
respective levels of sex hormones. Our findings correspond with
the majority of the literature; there were higher pro-inflammatory
responses in females compared to males.
When the effects of smoking status and IFNG T+ 874A geno-
type on IFN-γ levels were assessed, significant differences were
observed between genotypes among smokers. In general, the effect
of smoking was suppressive. The most dramatic effect was the 10-
fold decrease in the response to the lower dose of endotoxin in
smokers with the TT genotype compared to non-smokers. The
only increase in IFN-γ responses in those who smoked was in
individuals with the TA genotype when cells were stimulated with
TSST-1. This was the most common genotype observed among
SIDS infants from Hungary and Germany (Table 1).
The interaction of cigarette smoking with IFNG T+ 874A
genotypes on IFN-γ responses appears to be toxin specific. For
example, for TSST, the TA genotype was greatly affected by ciga-
rette smoke, while for endotoxin (0.01µml−1) the TT genotype
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was most significantly affected by smoking. It is common to find
conflicting data in the literature when assessing the function of a
SNP, particularly when stimulation conditions differ. In our study,
differences in responses were due to toxin type, as stimulation
conditions were the same. We could not, however, control for
asymptomatic infection or passive exposure to cigarette smoke
as cotinine levels were not assessed in the studies with samples
from SIDS parents and the unrelated comparison group.
There is little information in the literature on the effects of
the IFNG SNP on cytokine responses. Two groups have found the
TT genotype to be associated with increased IFN-γ production
(22, 33, 34); however, smoking or environmental tobacco smoke
(ETS) exposure had not been considered as a confounder. These
results again highlight the need to control for smoking status and
ETS exposure when assessing the effects of cytokine gene SNPs
in vitro.
We have observed similar interactions with cytokine gene SNPs
and smoking; IL-10 responses were significantly decreased in
smokers with the IL10 G-1082A AA genotype. IL-6 responses were
significantly increased in smokers with the IL6 G-174C GC (24,
25). Data from this study and previous findings suggest that expo-
sure to cigarette smoke alters cytokine responses more for some
genotypes than others.
There were significantly higher IFN-γ responses to TSST-1
from cells of donors with the TA genotype, and this was the
predominant genotype among SIDS infants from Germany and
Hungary (Table 1). Pyrogenic staphylococcal toxins have been
detected in over 50% of SIDS infants from five different countries
(20). Interactions between a mild virus infection and exposure to
cigarette smoke in an infant with the TA genotype might lead to
high levels of IFN-γ, which could result in significant down regu-
lation of IL-10 and dysregulation of pro-inflammatory responses
to pyrogenic toxins. In a vulnerable infant, this dysregulation
of inflammation could trigger the physiological events leading
to SIDS.
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